The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study
NCT02516683 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 229
Last updated 2015-08-06
Summary
Background: The incidence of postinfectious irritable bowel syndrome (PI-IBS) was reported to be in the range of 5-30%, but limited number of long-term follow-up results.
Objective: To investigate the long term clinical course of PI-IBS after Shigellosis.
Setting: A Shigellosis outbreak in a tertiary referral hospital with about 2,000 employees in Korea at 2001.
Patients: A Shigella-exposed cohort of 124 hospital employees who had been infected by Shigella sonnei due to contaminated food in the employee-cafeteria in Gangnam Severance Hospital, Seoul, Korea, at December 2001. A control cohort of age and sex-matched, non-infected 105 contemporary hospital employees.
Measurements: Questionnaire survey for bowel symptoms at 1, 3, 5, 8 and 10 years after outbreak.
Conditions
- Shigella Sonnei Infection
Interventions
- OTHER
-
Shigella sonnei infection
A Shigella-exposed cohort of 124 hospital employees who had been infected by Shigella sonnei due to contaminated food in the employee-cafeteria in Gangnam Severance Hospital, Seoul, Korea, at December 2001.
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Principal Investigators
-
Young Hoon Youn, MD, PhD · Yonsei University
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-12-31
- Primary Completion
- 2011-12-31
- Completion
- 2015-07-31
More Related Trials
-
Post-Infectious Irritable Bowel Syndrome (PI-IBS)
NCT01497847 ·Status: COMPLETED
-
Efficacy and Safety of Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome
NCT06697119 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Chronic Gastrointestinal Sequelae of an Acute Outbreak of Bacterial Gastroenteritis in Walkerton Ontario
NCT00235326 ·Status: COMPLETED
-
Effects of Faecal Microbiota Transplantation in Patients With IBS
NCT03822299 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea
NCT02651740 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1
-
FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment
NCT03125564 ·Status: COMPLETED ·Phase: NA
-
The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study
NCT01829932 ·Status: COMPLETED ·Phase: NA
-
The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients
NCT05972317 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Probiotics in Patients With IBD
NCT05652621 ·Status: RECRUITING ·Phase: NA
-
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569 ·Status: NOT_YET_RECRUITING
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome
NCT05819281 ·Status: UNKNOWN ·Phase: PHASE2
-
Exploring the Mechanism of a Probiotic Combination VSL#3 in Irritable Bowel Syndrome
NCT00786123 ·Status: COMPLETED ·Phase: NA
-
ID-JPL934 for Abnormal Bowel Movement
NCT03395626 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT05509725 ·Status: RECRUITING ·Phase: PHASE4
-
Comparison of Microbiota and Quality of Life for a Low FODMAPs and Standard Dietary in Irritable Bowel Syndrome Patients
NCT02902926 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Hydrogen Breath Test in the Patients With Irritable Bowel Syndrome
NCT02242175 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Small Intestinal Bowel Epithelial Gaps in Irritable Bowel Syndrome
NCT01632488 ·Status: UNKNOWN
-
A Multi-center Human Study to Evaluate the Efficacy and Safety of ®GI Flora in Subjects With Irritable Bowel Syndrome
NCT02419027 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT05740319 ·Status: RECRUITING ·Phase: NA
-
the Relationship Between Helicobacter Pylori Infection and Irritable Bowel Syndrome
NCT04847401 ·Status: UNKNOWN
-
Fecal Transplantation in Patients With IBS
NCT03333291 ·Status: COMPLETED ·Phase: NA
-
Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D
NCT04074421 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome
NCT01637714 ·Status: UNKNOWN ·Phase: NA